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Abstract Recent studies have demonstrated the biological 
importance of the interaction of S-nitrosothiols, which can be 
considered as nitric oxide (NO) protein donors, especially 
haemoglobin, at the level of Cys residues. It was recently 
proposed that S-nitrosohaemoglobin is formed within red blood 
cells and serves as a regulatory function. In human haemoglobin 
the ccrsubunit contains one Cys residue and the ß-subunit 
contains two Cys residues, one of which (ß-Cys93) is highly 
reactive and conserved among species, although its function has 
remained unknown. Electrospray ionization mass spectrometry 
was used to monitor the results of exposure of haemolysates to S-
nitrosocysteine under different conditions and thus addressed 
some aspects of NO-haemoglobin interaction. When an equi-
molar ratio of S-nitrosothiol was added to haemoglobin, only a 
single NO molecule was added. Peptide mapping by liquid 
chromatography-mass spectrometry located the nitrosyl group 
at the level of ß-Cys93 demonstrating that this was the preferred 
site of formation of S-nitrosohaemoglobin. The present data also 
suggest that electrospray mass spectrometry can allow quanti-
fication and characterisation of S-nitrosoproteins in blood. 
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1. Introduction 
The interaction of nitric oxide (NO) with proteins is known 
to play a critical role in several different physiological systems 
extending from blood pressure regulation to neurotransmis-
sion [1-3]. In addition, NO produced in infected and inflamed 
tissue could contribute to the process of carcinogenesis [4,5]. 
Although NO has been known since the late 1970s to be 
among the ligands that activate soluble guarníate cyclase 
and cause vascular smooth muscle relaxation, it has not 
been appreciated until more recently that NO is also an en-
dogenous vasorelaxant. NO and endothelium-derived relaxant 
factor (EDRF) comparably relax vascular smooth muscle and 
are similarly quenched by haemoglobin and Superoxide. 
Therefore it was proposed that EDRF is NO or a labile com-
pound releasing NO, such as S-nitrosothiols (RSNO), the 
most abundant being S-nitrosocysteine (Cys-NO) and S-nitro-
soglutathione. The target of NO on proteins are Cys and Tyr 
residues and bound metals such as heme-Fe2+ (for a recent 
review see [6]). Although much work has been performed in 
characterising the NO-Fe2 + interaction [7,8], there is consid-
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erably less data on the Cys-NO interactions. In fact, RSNOs 
are unstable in aqueous solution. It has been assumed that the 
lability of RSNOs is due to their propensity to undergo homo-
lytic cleavage of the S-N bond with release of NO [9]. The 
quantitative contribution of labile NO donors such as RSNOs 
to EDRF is not yet well established, but it is clear that such 
compounds are formed in vivo and have biological activity. 
Thiol formation is considered a likely outcome of Cys-NO 
interaction at acidic pH. At physiological pH, RSNO forma-
tion is thought to be less favourable, although RSNO on 
proteins has been found in vitro [10] and in vivo [11]. The 
ß-chain of haemoglobin possesses a highly reactive thiol group 
at position 93 [12] which is conserved among mammalian 
species and, although its function remains unknown, it has 
been recently proposed that it can interact with endogenous 
RSNOs to form NO-Hb, suggesting that this may serve for 
regulation of blood pressure and facilitates efficient delivery of 
oxygen to tissues [13]. However, as yet no structural data have 
been produced to support the preferential formation of N O -
Hb at ß-Cys93. 
We used ES/MS to monitor the exposure of haemoglobin to 
Cys-NO under different conditions and to determine the cys-
teine residue involved in the formation of NO-Hb. We dem-
onstrated that ß-Cys93 is the preferred site of in vitro NO-Hb 
formation, whereas ß-Cys112 and cc-Cys104 form NO-Hb only 
in the presence of very high levels of RSNOs. 
2. Materials and methods 
2.1. Materials 
Blood samples were collected from normal volunteers immediately 
prior to their use for in vitro incubation. Pepsin, sodium nitrite, L-
cysteine, glycerol and thioglycerol were purchased from Sigma (St. 
Louis, MO). Sodium phosphate, sodium ethylenediaminetetracetate 
(EDTA), hydrochloric acid, HPLC-grade solvents and reagents were 
obtained from Carlo Erba (Milan, Italy). Phenylisothiocyanate 
(PITC) was purchased from Fluka (Buchs, Switzerland). 
2.2. Preparation of S-nitrosothiol solutions 
Solutions (50 mM) of Cys-NO were prepared by mixing equal 
volumes of 100 mM L-cysteine in 250 mM HC1, 0.1 mM Na2EDTA 
with 100 mM NaN02 in water at room temperature. Previous studies 
have established that essentially no nitrite remains in the nitrosothiol 
solutions using this synthetic method [9]. 
2.3. In vitro incubation 
Human erythrocytes from a normal volunteer were washed in iso-
tonic saline as described previously [14] and then lysed by addition of 
an equal volume of water. This oxy-Hb (about 1 mM) was estimated 
by SDS-gel electrophoresis and by isoelectric focusing (IEF) to be 
about 95% pure and was prepared immediately prior to its use. 
Incubations of Cys-NO with these fresh haemolysates (200 μΐ) were 
performed at 25°C for 30 min, using 1 :10 and 1 :100 haemoglobin/ 
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Cys-NO, respectively, in 1 ml total volume by addition of aerate 
phosphate buffer, pH 7.4, 0.5 mM EDTA and subsequently of the 
RSNO solution. The reactions were stopped by dilution of the sam-
ples with 400 μΐ of 0.1% TFA. A total of 200 μΐ of this solution was 
injected on the HPLC column. 
2.4. HPLC separation of globin chains 
Globin chains were purified by RP-HPLC using the procedure de-
veloped by Shelton et al. [15] with the following modifications: the 
samples (500 μg of globin dissolved in 100 μΐ of TFA 0.1% in water) 
were loaded onto a Vydac C4 large-pore column equilibrated in the 
following buffer: (A) 80:20 water/acetonitrile, 0.1% TFA; (B) 40:60 
water/acetonitrile, 0.1% TFA. The column was equilibrated at 52% of 
buffer B. After a 2-min hold, buffer B was raised to 69% in 24 min. 
Before analysis globin samples were filtered through a 45 um filter 
(Millipore). For analytical runs 100 μg samples were used. The col-
umn effluent was monitored at 280 nm. Protein fractions were manu-
ally collected and directly injected into the ES/MS source. 
2.5. Electrospray mass spectrometry 
ES/MS analyses of intact globin chains were performed with a 
PLATFORM mass spectrometer (Fisons, Manchester, UK). Samples 
from the HPLC separation (10 μΐ, 50 pmol) were injected into the ion 
source at a flow rate of 10 μΐ/min; the ES-mass spectra were scanned 
from 1600 to 600 u at a scan cycle of 10 s/scan. The source tempera-
ture was 65°C. Mass scale calibration was carried out using myoglo-
bin as reference compound. Quantitative analysis of components was 
performed by integration of the multiple charged ions of the single 
species. 
2.6. Peptic digestion 
Peptic hydrolysis was carried out in 5% formic acid, at 37°C for 1.5 
h in a haemoglobin/enzyme ratio of 50:1 (w/w). The reaction was 
stopped by freeze-drying. 
2.7. LCIESIMS peptide mapping 
Liquid chromatography was performed using a 2.1 mm i.d. X250 
mm, C18, 5 μηι (Vydac) reverse-phase column with a flow rate of 0.2 
ml/min on a Kontron modular system. The column effluent was spht 
1 :25 with a Valco tee, to give a flow rate of about 8 ml/min into the 
electrospray nebuliser. The bulk of the flow was run through the 
detector for peak collection as measured by following the absorbance 
at 220 nm. Solvent A was 0.03% TFA (v/v) in water; solvent B was 
0.02% TFA in acetonitrile. Separation of the peptides was effected 
with a gradient 5-45% B in 60 min. The ES-mass spectra were 
scanned from 1800 to 400 u at a scan cycle of 5 s/scan. The source 
temperature was 120°C. Different conditions of the orifice voltage 
were employed (20-80 V). 
2.8. Assignment of modified cysteine residues 
The HPLC fractions containing the nitrosylated peptides were lyo-
philised and redissolved in 0.4% ammonium bicarbonate, pH 9.0, for 
2 h. The reaction was stopped by freeze-drying and the samples were 
analysed by FAB-MS/MS. 
2.9. FAB mass spectrometry 
FAB mass spectra were performed on a ZAB 2SE (Fisons, Man-
chester, UK) double-focusing, reversed-geometry mass spectrometer 
equipped with a caesium gun operating at 25 kV (2 mA). The sample 
was dissolved in 0.1 M HC1 and loaded on to a glycerol/thioglycerol-
coated probe tip. 
High-energy collision induced-dissociation (CID) mass spectra were 
obtained on a ZAB-T (Fisons, Manchester, UK) four-sector 
(B1E1B2E2) mass spectrometer under control of an OPUS V3.1X 
data system and equipped with a 2048 channel-linear photo diode 
focal plane array detector. The sample was bombarded with a beam 
of Cs+ ions having an energy of 30 keV. Analyses were performed at 
8 kV accelerating potential. For collision-induced decomposition ex-
periments, argon collision gas was used up to 50% attenuation of the 
parent ion beam. The collision cell was held on 50% of the accelerat-
ing potential. For each spectrum, 100-200 pmol of sample was dis-
solved in 1 μΐ of 5% acetic acid, and this solution was placed on the 
glycerol/thioglycerol (1 :1) matrix on the probe tip. Signals recorded 
in the spectra were assigned to the corresponding peptides on the basis 
of the expected molecular weight by using a suitable computer pro-
gram reference. 
2.10. Edman degradation 
Manual Edman degradation steps were carried out directly on the 
peptide mixtures using 5% phenylisothiocyanate as coupling agent, as 
described previously [16]. 
3. Results 
Globins in the haemolysate, following incubation with Cys-
NO in a 1 :10 molar ratio, were separated by reverse phase 
HPLC (Fig. 1). When compared with a standard haemolysate 
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Fig. 1. HPLC separation of S-nitrosohaemoglobin. a: Standard hae-
molysate. b: Sample incubated with a Hb/Cys-NO ratio (1 :10). c: 
Sample incubated with a Hb/Cys-NO ratio (1 :100). A,A',A" = a-
globin and nitrosylated derivatives; Β,Β' = ß-globin and nitrosylated 
derivative. 
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a 
ß-globin 
theoretical M.W.: 15867.2 Da 
experimental M.W.: A= 1586S.5±!.4Da 
A'=15897.8±l.l Da 
./^"V 
α-globin 
theoretical M.W.: 15126.4 Da 
experimental M.W.:B=15126.5±1.1 Da 
Fig. 2. ES/MS spectra in the transformed mass scale of globin 
chains from haemoglobin incubated with Hb/Cys-NO ratio (1 :10). 
a: ß-Globin chain, b: a-Globin chain. 
togram obtained for the peak of the modified ß-globin is 
shown in Fig. 4. HPLC peaks were assigned to peptides within 
the globin sequence on the basis of the measured molecular 
weight (Table 1). When necessary the assignments were con-
firmed by submitting the collected HPLC peaks to FAB/MS 
analysis prior to and after one or more manual Edman deg-
radation steps, as previously described [16]. It can be ob-
served that the entire ß-globin sequence was actually checked 
out by this procedure (see Table 1). 
The peak at 30.9 min (fraction 19) in the chromatogram of 
Fig. 4a contained a peptide with a molecular weight of 
2052.6 ±0.2 which was assigned to peptide 89-105 (molecular 
weight: 2052.3) containing ß-Cys93. This peak was also pres-
ent in the spectrum of unmodified ß-globin (Fig. 4b). A novel 
peak was instead found at a higher retention time (31.9 min, 
fraction 21) containing two mass signals 2052.3 ±0.7 and 
2081.3 ±0.7 (Aw = 29 mass units) corresponding to the mass 
of unmodified and nitrosylated peptide 89-105, respectively. 
Fraction 21 was collected and analysed by ES/MS at differ-
ent cone voltage values. In Fig. 5 the ES mass spectra ob-
tained at 20, 40 and 80 V are shown. At the lower voltage 
essentially the modified peptide was present (2081.6 ±0.7). In-
creasing of the cone voltage led to a higher fragmentation and 
at 80 V only the peak at 2052.5 ± 0.3 was observed, whereas at 
the higher voltage only the native peptide was found. The 
above findings unambiguously demonstrated that the signal 
at the lower mass was due to a fragmented species arising 
from the nitrosylated peptide. 
The identity of the modified peptide 89-105 was also con-
firmed by incubation at alkaline pH, after which the peptide 
(Fig. la), the HPLC profile showed a double shaped peak at 
the ß position (Fig. lb). Direct analysis by ES/MS of the 
modified samples collected during the HPLC run allowed ac-
curate molecular weight determination as shown in Fig. 2. 
The mass measured for the oc-chain (15126.5 ± 1.1) peak 
(Fig. 2b) perfectly matched with that of the native globin 
(15126.4). Of the two species present at the ß position (Fig. 
2b), the first was the native ß-globin (15868.5 ± 1.4, expected 
mass 15867.2) whereas the second had a mass of 15897.8 ±1.1 
with a shift of +29 units compared with that measured for the 
ß-globin, indicating the addition to the protein of a single NO 
moiety. 
In contrast, Fig. lc shows the HPLC profile and Fig. 3 the 
corresponding mass spectra obtained after incubation at a 
higher Hb/Cys-NO ratio (1 :100). ES/MS analysis showed 
that both a- and ß-globins had a mass shift with respect to 
the native chains. The α-chain was present either as the un-
modified and the mono-nitrosylated species (measured mass: 
15125.5± 1.1 and 15164.1 ±2.2, respectively), while in the ES 
spectrum of the ß-chain components were observed containing 
zero, one and two nitrosyl-groups (15867.2 ±0.7, 15896.0 ±0.5 
and 15924.0 ±1.6, respectively). These data indicated that at 
this level of nitrosylating agent, a non-selective modification 
occurred involving the two cysteines of the ß-chain and the 
single cysteine of the cc-chain. Therefore we focused our atten-
tion on the NO-Hb obtained by using the lower Cys-NO 
ratio, in order to determine the preferential site of the ß-glo-
bin nitrosylation. 
The peptic digest of the modified globins after incubation 
with 1 :10 RSNO was separated by LC/ES/MS. The chroma-
' ß-globin 
theoretical M.W.: 15867.2 Da 
experimental M.W.: A= 15867.2±0.7 Da 
X= 15896.0±0.5 Da 
A"= 15924.0 ±1.6 Da 
.ß 
a-globin 
theoretical M.W.: 15126.4 Da 
experimental M.W.: B= 15125.5 + 1.1 Da 
B'= 15164.1 ±2.2 Da 
Fig. 3. ES/MS spectra in the transformed mass scale of globin chain 
from haemoglobin incubated with Hb/Cys-NO ratio (1 :100). a: ß-
Globin chain, b: a-Globin chain. 
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Table 1 
Analysis by LC/ES/MS of the products of digestion of beta-Hb-NO with pepsin 
HPLC peak* Theoretical mass Peptidec Measured massb Note 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
654.7 
709.7 
767.9 
706.9 
1306.4 
1335.4 
1758.0 
1119.3 
1819.1 
2063.3 
2205.6 
1635.7 
n.d. 
1664.7 
817.9 
2543.9 
1342.5 
1180.3 
1494.7 
1869.1 
1229.4 
1472.6 
2052.3 
3525.0 
2205.6 
1980.2 
2052.3 
2081.3 
3001.4 
2738.1 
1634.8 
816.0 
929.2 
3046.5 
1634.9 
3600.1 
3388.9 
2205.6 
3821.4 
3675.2 
1308.5 
4107.7 
3674.9 
142-146 
97-102 
141-146 
130-135 
92-102 
(92-102)+NO 
22-37 
130-140 
32-45 
43-62 
49-70 
89-102 
n.d. 
(89-102)+NO 
7-14 
122-145 
33^12 
136-146 
1-14 
130-146 
86-96 
15-28 
89-105 
33-63 
49-70 
118-135 
89-105 
(89-105)+NO 
42-70 
115-140 
71-85 
107-114 
106-114 
49-78 
19-41 
15-45 
49-81 
49-70 
45-81 and 49-85 
46-81 and 49-84 
32-41 
45-84 
46-81 and 49-84 
654.7 ±0.2 
709.6 ±0.2 
767.6 ±0.2 
706.6 ±0.2 
1306.5 ±0.9 
1336.3 ±0.1 
1757.2 ±0.9 
1118.6±0.3 
1818.9±0.7 
2063.6 ±0.5 
2205.3 ±0.2 
1635.1 ±0.2 
= 
1664.2 ±0.1 
817.8 ±0.2 
2542.5 ±0.1 
1341.5 ±0.5 
1180.5 ±0.1 
1494.9 ±0.5 
1870.5 ±0.9 
1229.7 ±0.6 
1473.1 ±0.7 
2052.6 ±0.2 
3524.7 ±0.5 
2205.8 ±0.7 
1980.9 ±0.8 
2052.3 ±0.7 
2081.6 ±0.7 
3001.5 ±0.8 
2738.7 ±0.7 
1634.3 ±0.2 
815.8 ±0.2 
928.1 ±0.2 
3046.0 ±0.4 
1634.6 ±0.4 
3601.1 ±0.9 
3388.5 ±0.8 
2205.3 ±0.1 
3821.5 ±0.2 
3675.1 ±0.5 
1308.8 ±0.9 
4016.9 ±0.3 
3674. ±0.7 
Cys93-NO 
Cys93-NO 
Cys93-NO 
"Numbers refer to the peaks of the chromatogram shown in Fig. 4. 
bAverage molecular masses in DA (mean ± S.D.) obtained by integrating the multiple peaks corresponding to each molecular species, differing only 
in the total number of charges, measured by LC/ES/MS. 
cNumbers indicate the amino acid residues at the extremes of each peptide. 
at 2081.6 shifted to 2052.3, due to hydrolysis of the S-NO 
bond. FAB-MS/MS analysis (not shown) fully confirmed the 
sequence of peptide 89-105. 
The only modified peptides were those including ß-Cys93 
(peptides 92-102, 89-102 and 89-105). It should be noted 
that no trace of modified peptides containing ß-Cys112 was 
detected, which indicated that nitrosylation selectively oc-
curred at the level of ß-Cys93. 
The globin chains modified following incubation with 
1 :100 Hb-NO were analysed with the same procedure (not 
shown). This analysis confirmed that at this higher ratio, all 
the cysteine residues in the a- and ß-chains were partially 
nitrosylated. 
4. Discussion 
4.1. Analytical model for the determination of nitrosylated 
cysteines in haemoglobin 
The need for methods to evaluate the action of exogenous 
as well as endogenous agents has stimulated studies on their 
reactivity with biomolecules. Ideally, methods are desirable 
which detect any modification in the intact protein easily 
and rapidly and identify the specific nature and sites of mod-
ification. Recent advances have made mass spectrometry the 
method of choice to address structural problems involving 
covalently modified proteins [17]. Furthermore, mass spectro-
metric methods are virtually independent from the type of 
modification to be identified and therefore ideally suited to 
the study of covalent modification of proteins. Molecular 
weight measurement by ES/MS was instrumental in the im-
mediate evaluation of the degree of modification of the globin 
chains. This technique can be applied to the analysis of pur-
ified globin as well as to direct examination of haemolysates 
without the need for adduct purification. Modified species can 
be identified even in the case of NO, where the mass difference 
due to the reaction is only 29 mass units, as previously dem-
onstrated in the case of nitrosylated peptides [18]. 
The present study based on the analysis of the adducts of 
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Fig. 4. LC/ES/MS of the peptic digest of the mononitrosyl ß-globin 
(a), compared with that of native ß-globin (b). 
reversibly modified by RSNOs in red blood cells. A similar 
result for another highly reactive electrophilic agent such as 
methyl bromide was recently observed [19]. The different be-
haviour exhibited by ß-Cys93 compared to the other cysteine 
residues is in agreement with the already reported in vivo 
reactivity of this residue in oxy-haemoglobin which readily 
undergoes oxidation to form mixed disulphides and other 
thioethers due to its position within the protein quaternary 
structure [20]. 
Once formed, Hb-NO adducts are readily degraded at neu-
tral or alkaline pH [9]. For this reason nitrosylated peptides 
were not observed after tryptic hydrolysis (data not shown). A 
much greater stability of the nitrosylated globins was instead 
observed at low pH. Samples stored at pH < 3 showed mini-
mal degradation over a period of several weeks. For this rea-
son a procedure based on the use of pepsin as the proteolytic 
agent was chosen, which allowed us to preserve nitrosylated 
peptides during hydrolysis at low pH values. 
The peptic mixture was directly analysed in LC/ES/MS. 
Enzymatic digestion of modified haemoglobin resulted in a 
mixture of native and nitrosylated peptides, the relative abun-
dance depending on the extent of overall nitrosylation. The 
presence of overlapping peptides due to incomplete digestion 
was useful in obtaining a complete peptide map and in the 
accurate location of the modified cySteines. Nitrosylated pep-
tides were readily identified from their molecular weight com-
pared to the native ones and their identity was confirmed by 
haemoglobin-NO was aimed at (i) verifying the overall reac-
tivity of haemoglobin towards nitric oxide and at evaluating 
the level of modification, and (ii) identifying the actual mod-
ified cysteine(s) among those contained in the haemoglobin 
sequence. This study reports the identification of the unique 
reactive cysteine of haemoglobin following in vitro exposure 
of haemolysates at low Cys-NO/Hb ratio. 
4.2. Nitric oxide induces modification of a specific cysteine 
residue in haemoglobin 
A recent study [13] reported that NO-Hb can be formed in 
vitro and in vivo in the presence of RSNOs, and NO-Hb has 
been involved in blood pressure regulation. It was reported 
that no modified residue occurred different from ß-Cys93, but 
no structural data were available on the nature of the N O -
Hb. These conflicting observations prompted us to undertake 
this study. To selectively nitrosylate the thiol group of cysteine 
residues a procedure involving RSNO intermediates was cho-
sen [9]. This allowed us to monitor the reactivity of cysteine 
residues within the haemoglobin sequence. We varied the ratio 
of reagent to protein to determine some degree of selectivity. 
In fact, the use of NO at two different concentrations allowed 
determination of the level at which side chain reactivity was 
modulated by the NO/haemoglobin ratio. We actually demon-
strated that under the conditions used by Jia et al. [13] only a 
single cysteine residue, ß-Cys93, is almost completely modified 
in vitro after 30 min. At longer times (2 h) the reaction is 
complete and no further modification is observed (not shown). 
It is worth mentioning that using a higher concentration of 
nitrosothiol (1 :100), modification at ß-Cys112 and a-Cys104 
also occurred. However, this concentration appears to be far 
from showing real physiological significance [13]. Therefore 
one can reasonably conclude that only ß-Cys93 is actually 
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Fig. 5. ES/MS spectra of nitrosylated peptide (89-105) obtained at 
different values of cone voltage: a = 20 V, b = 40 V, c = 80 V. 
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nitrosylated ß-globin 
ß-globin 
α-globin 
mass 
Fig. 6. ES/MS spectrum of haemolysate incubated with Hb/Cys-NO ratio (1 :10). The mtrosyl derivative haemoglobin can be observed. 
selective fragmentation at the S-NO bond by increasing the 
cone voltage. 
In addition, the proposed approach can also be applied to 
monitor in vivo modification. In fact, in Fig. 6, the spectrum 
of a whole haemolysate treated with 1 :10 Cys/NO is re-
ported, which demonstrates the possibility to extend the in 
vivo the direct analysis the NO-adducts in blood. Considering 
the extremely variable and httle-known in vivo reactivity of 
NO with proteins, the proposed methodology may represent a 
practical approach both for the analysis of the NO-protein 
adducts and for the assignment of NO-modified residues in 
polypeptide chains. 
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